Tharimmune, inc. THAR.US AI Analysis
BetaUS StockHealthcare
(No presentation for THAR)
THAR Value Score
3
24
15
Limited Growth
Analysis Conclusion
The stock has a lower value rating; if aiming for value investing, existing long-term positions might require gradual reduction.
THAR Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of THAR from 2022-01-12 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from January, 2022 to July, 2025. (Total Trades: 0)
| THAR | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 49% | 58% |
| Avg Return | - | 47.2% | 61.1% |
| Avg Profit | - | 139.7% | 128.2% |
| Avg Loss | - | -40.5% | -32% |
| Avg Risk-Reward Ratio | - | 344.6% | 400.6% |